Huntingtons Disease Treatment Market, By Diagnosis Type (Diagnostic Imaging and Genetic Testing), By Treatment Type, By Drug Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Huntington’s Disease Treatment Market size was valued at USD 450.90 million in 2023, expanding at a CAGR of 24.10% from 2024 to 2032.
Huntington\'s disease is a rare genetic disorder that currently has no cure and causes the deterioration of brain cells. Early signs often include problems with coordination and occasional memory lapses. This disease has a significant impact on a person\'s motor skills, cognitive functions, and overall mental health. The rarity of Huntington\'s disease is notable, as it is usually passed down through a mutated gene from one of the parents. The disorder mainly results in a range of movement difficulties, as well as mental health challenges and issues with cognitive processes like planning and reasoning. According to the Genetic and Rare Diseases Information Center (GARD), there are fewer than 5,000 individuals in the United States living with Huntington\'s disease.
Huntington’s Disease Treatment Market- Market Dynamics
The surge in Huntington’s disease cases and the escalating requirement for cutting-edge drugs to address the disease are projected to fuel market growth
Increased knowledge about Huntington\'s disease, along with advancements in diagnostic tools, is enabling early identification and intervention, leading to a rise in the need for treatment choices. This degenerative brain condition affects around 3 to 7 people per 100,000, mainly in individuals of European ancestry. Pharmaceutical companies and research institutions are dedicating significant resources to research and development to discover new treatment options and improve existing therapies, thereby fueling the growth of the market. Furthermore, advancements in drug research offer additional possibilities for market expansion. However, a lack of awareness in developing areas could impede the progress of the market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Pfizer Inc.
Alnylam Pharmaceuticals Inc.
Ceregene Inc.
Prana Biotechnology Limited
Teva Pharmaceutical Industries Ltd
Ionis Pharmaceuticals
Neurocrine Biosciences Inc.
Prilenia Therapeutics
Azevan Pharmaceuticals
Lundbeck
PTC Therapeutics
UniQure
Others
GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2019 - 2032
Diagnostic Imaging
Genetic Testing
Others
GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032
Symptomatic Therapy
Disease-Modifying Therapy
Others
GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
Tetrabenazine
Deutetrabenazine
Other Drugs
GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
GLOBAL HUNTINGTON’S DISEASE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Huntington’s Disease Treatment Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Huntington’s Disease Treatment Market Snippet by Diagnosis Type
2.1.2. Huntington’s Disease Treatment Market Snippet by Treatment Type
2.1.3. Huntington’s Disease Treatment Market Snippet by Drug Type
2.1.4. Huntington’s Disease Treatment Market Snippet by End-User
2.1.5. Huntington’s Disease Treatment Market Snippet by Country
2.1.6. Huntington’s Disease Treatment Market Snippet by Region
2.2. Competitive Insights
3. Huntington’s Disease Treatment Key Market Trends
3.1. Huntington’s Disease Treatment Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Huntington’s Disease Treatment Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Huntington’s Disease Treatment Market Opportunities
3.4. Huntington’s Disease Treatment Market Future Trends
4. Huntington’s Disease Treatment Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Huntington’s Disease Treatment Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Huntington’s Disease Treatment Market Landscape
6.1. Huntington’s Disease Treatment Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Huntington’s Disease Treatment Market – By Diagnosis Type
7.1. Overview
7.1.1. Segment Share Analysis, By Diagnosis Type, 2023 & 2032 (%)
7.1.2. Diagnostic Imaging
7.1.3. Genetic Testing
7.1.4. Others
8. Huntington’s Disease Treatment Market – By Treatment Type
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
8.1.2. Symptomatic Therapy
8.1.3. Disease-Modifying Therapy
8.1.4. Others
9. Huntington’s Disease Treatment Market – By Drug Type
9.1. Overview
9.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
9.1.2. Tetrabenazine
9.1.3. Deutetrabenazine
9.1.4. Other Drugs
10. Huntington’s Disease Treatment Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
10.1.2. Hospital Pharmacies
10.1.3. Retail Pharmacies
10.1.4. Online Pharmacies
11. Huntington’s Disease Treatment Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Huntington’s Disease Treatment Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Huntington’s Disease Treatment Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Huntington’s Disease Treatment Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Huntington’s Disease Treatment Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Huntington’s Disease Treatment Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Huntington’s Disease Treatment Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Pfizer Inc.
12.2.2. Alnylam Pharmaceuticals Inc.
12.2.3. Ceregene Inc.
12.2.4. Prana Biotechnology Limited
12.2.5. Teva Pharmaceutical Industries Ltd
12.2.6. Ionis Pharmaceuticals
12.2.7. Neurocrine Biosciences Inc.
12.2.8. Prilenia Therapeutics
12.2.9. Azevan Pharmaceuticals
12.2.10. Lundbeck
12.2.11. PTC Therapeutics
12.2.12. UniQure
12.2.13. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
